Company intelligence / Profile preview

MTPConnect

Brighton, Victoria, Australiamtpconnect.org.au ↗

Ownership: Private
Development stage: Other

Overview

MTPConnect has invested over A$152 million in 199+ projects since inception. Its programs have led to the creation of 37 new products and over 1,696 new technologies. The organisation’s activities have generated more than $7.5 billion in economic impact for Australia’s life sciences sector by supporting start-ups and SMEs with funding and strategic connections.

Therapeutic areas: Rare DiseasesEndocrinologyCardiovascularInfectious Diseases
Modalities: Small moleculesBiologics (including mAbs)Medical devicesDiagnosticsDigital health technologies
Industry: Investors

Partnerships

CSL Limited (industry partner for TTRA program)Roche Diagnostics (industry partner for TTRA program)BioCom California & Korean Health Industry Development Institute (international collaboration on clinical trials)

Beyond the preview

Go deeper on MTPConnect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTPConnect.

Explore the full profile